For patients with EGFR-sensitive mutated NSCLC, a number of clinical studies have confirmed that consolidation radiotherapy during EGFR-TKIs significantly prolongs PFS and total OS (126, 127). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.